Form 8-K - Current report:
SEC Accession No. 0001079973-24-001282
Filing Date
2024-08-19
Accepted
2024-08-19 16:47:59
Documents
19
Period of Report
2024-08-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K scpx_8k.htm   iXBRL 8-K 46618
2 UNDERWRITING AGREEMENT ex1x1.htm EX-1.1 292786
3 PRE-FUNDED COMMON STOCK PURCHASE WARRANT ex4x1.htm EX-4.1 102471
4 EXHIBIT 99.1 ex99x1.htm EX-99.1 8605
5 EXHIBIT 99.2 ex99x2.htm EX-99.2 6239
6 GRAPHIC image_001.jpg GRAPHIC 5337
  Complete submission text file 0001079973-24-001282.txt   790923

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE scpx-20240816.xsd EX-101.SCH 3549
8 XBRL DEFINITION FILE scpx-20240816_def.xml EX-101.DEF 26579
9 XBRL LABEL FILE scpx-20240816_lab.xml EX-101.LAB 36527
10 XBRL PRESENTATION FILE scpx-20240816_pre.xml EX-101.PRE 25203
21 EXTRACTED XBRL INSTANCE DOCUMENT scpx_8k_htm.xml XML 5512
Mailing Address 627 DAVIS DRIVE SUITE 300 MORRISVILLE NC 27560
Business Address 627 DAVIS DRIVE SUITE 300 MORRISVILLE NC 27560 919-240-7133
Scorpius Holdings, Inc. (Filer) CIK: 0001476963 (see all company filings)

EIN.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35994 | Film No.: 241221282
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)